Siamycin-1 | Interleukin Related interleukin-related.com

Product Name :
Siamycin-1

Search keywords :
Siamycin I

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
HIV fusion inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
HIV Infections

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Src Antibody
DYKDDDDK Tag (FLAG) Antibody
Erk1 (pT202/pY204)+Erk2 (pT185/pY187) Antibody (YA455): Erk1 (pT202/pY204)+Erk2 (pT185/pY187) Antibody (YA455) is a non-conjugated and Rabbit origined monoclonal antibody about 41/43 kDa, targeting to Erk1 (pT202/pY204) + Erk2 (pT185/pY187). It can be used for WB,IP,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts